Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
Clinical trial NCT03642262 · COMPLETED
Trial details
- NCT number
- NCT03642262
- Sponsor
- Reckitt Benckiser Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-02
- Primary completion
- 2013-08-09
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.